75 related articles for article (PubMed ID: 20014304)
1. Can mobile units improve the strategies for cervical cancer prevention?
Mauad EC; Nicolau SM; Gomes UA; da Costa Vieira RA; de Castro Mattos JS; Longatto-Filho A; Baracat EC
Diagn Cytopathol; 2010 Oct; 38(10):727-30. PubMed ID: 20014304
[TBL] [Abstract][Full Text] [Related]
2. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
[TBL] [Abstract][Full Text] [Related]
3. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
4. Papanicolaou screening in developing countries: an idea whose time has come.
Suba EJ; Raab SS;
Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
6. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
Koval AE; Riganti AA; Foley KL
N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
[TBL] [Abstract][Full Text] [Related]
7. Use of laboratory reports to assess cervical cancer screening in a community.
Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
[TBL] [Abstract][Full Text] [Related]
8. Uptake of cervical cancer screening in The Netherlands is mainly influenced by women's beliefs about the screening and by the inviting organization.
Tacken MA; Braspenning JC; Hermens RP; Spreeuwenberg PM; van den Hoogen HJ; de Bakker DH; Groenewegen PP; Grol RP
Eur J Public Health; 2007 Apr; 17(2):178-85. PubMed ID: 16837520
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
10. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
[TBL] [Abstract][Full Text] [Related]
11. Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer.
Belkar R; Fiebig DG; Haas M; Viney R
Health Econ; 2006 Jan; 15(1):33-47. PubMed ID: 16145719
[TBL] [Abstract][Full Text] [Related]
12. Hispanic acculturation and utilization of cervical cancer screening in the US.
Shah M; Zhu K; Wu H; Potter J
Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
[TBL] [Abstract][Full Text] [Related]
13. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
[TBL] [Abstract][Full Text] [Related]
14. Mobilization for cervical cancer screening: lessons from a poor-urban Yoruba community in Nigeria.
Thomas JO; Babarinsa IA; Ajayi IO; Fawole O; Ojemakinde KO; Omigbodun AO
Afr J Med Med Sci; 2005 Mar; 34(1):81-5. PubMed ID: 15973782
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
16. Inadequate cervical cancer screening among mid-aged Australian women who have experienced partner violence.
Loxton D; Powers J; Schofield M; Hussain R; Hosking S
Prev Med; 2009 Feb; 48(2):184-8. PubMed ID: 19026675
[TBL] [Abstract][Full Text] [Related]
17. Participation in highly subsidized cervical cancer screening by women in Enugu, South-east Nigeria.
Obi SN; Ozumba BC; Nwokocha AR; Waboso PA
J Obstet Gynaecol; 2007 Apr; 27(3):305-7. PubMed ID: 17464818
[TBL] [Abstract][Full Text] [Related]
18. State-level differences in breast and cervical cancer screening by disability status: United States, 2008.
Armour BS; Thierry JM; Wolf LA
Womens Health Issues; 2009; 19(6):406-14. PubMed ID: 19879454
[TBL] [Abstract][Full Text] [Related]
19. Pap smear screening in a health maintenance organization: 1986-1990.
Rolnick S; LaFerla JJ; Wehrle D; Trygstad E; Okagaki T
Prev Med; 1996; 25(2):156-61. PubMed ID: 8860280
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
